Nuveen
SPTX icon

Nuveen’s Seaport Therapeutics SPTX Stock Holding History

Nuveen’s Portfolio SPTX Stock Details SPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$375K Buy
+18,603
New +$413K ﹤0.01% 3535

Other funds holding SPTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Nuveen's SPTX Position: Q3 2026 in Review

Nuveen opened a new position in Seaport Therapeutics (SPTX) in Q3 2026: 18,603 shares worth $375K. The stake represents ﹤0.01% of the portfolio and ranks #3535 among its holdings.

21 funds tracked by Wall St. Rank hold SPTX as of Q3 2026.

  • Nuveen held 18,603 shares of Seaport Therapeutics worth $375K as of Q3 2026.
  • Seaport Therapeutics was a new Nuveen position in Q3 2026.
  • Seaport Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #3535 holding.
  • 21 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.